Over 10 million personal records of Excellus BlueCross BlueShield customers were jeopardized when hackers gained access to the health plan's database.
Over 10 million personal records of Excellus BlueCross BlueShield and customers were jeopardized when hackers gained access to the health plans database.
The company discovered the crime on August 5, but the actual attack had occurred years back on December 23, 2013. According to Christopher Booth, president and CEO of Excellus BlueCross BlueShield, the hackers gained access to customers' names, dates of birth, Social Security numbers, mailing addresses, telephone numbers, member identification, financial account information and claims information, which would likely include medical data.
An internal investigation did not reveal any fraudulent use of the data.
Read more on Modern Healthcare.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Homelessness Compounds Hospital Stay Challenges: Study Reveals Prolonged Discharge Struggles
March 28th 2024In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a homeless population, and whether age and/or injury severity had an influence on that relationship—with implications for improving the discharge process for these patients.
Read More
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More